Routine compensation grants 562 MET shares to director Laura Hay

Rhea-AI Filing Summary

Form 4 highlights

On 06/17/2025, MetLife, Inc. (MET) filed a Form 4 disclosing that non-management director Laura J. Hay acquired 562 shares of common stock at an implied transaction price of $77.85 per share. The stock represents the portion of the regular board retainer that is paid in equity; the director chose to defer receipt through the company’s Deferred Compensation Plan for Non-Management Directors.

Following the issuance, Hay’s direct beneficial holdings increased to 3,701 shares. No shares were sold and no derivative positions were created or exercised. The filing contains no other transactions or amendments, and there are no indications of a Rule 10b5-1 trading plan.

Given MetLife’s market capitalization and share count, the transaction is immaterial from a valuation standpoint and is considered routine insider compensation rather than an open-market purchase. It nevertheless confirms continued equity alignment between the board and shareholders.

Insights

Financial Analyst

TL;DR – Routine director stock grant; negligible market impact.

The Form 4 shows 562 shares issued to non-management director Laura Hay as part of the standard board retainer. At roughly US$44 k in value, this adds less than 0.0001 % to MetLife’s share count and does not alter insider ownership meaningfully. Because the shares are deferred, immediate float impact is zero. No red flags appear: no sales, no derivatives, no executive departures. Investors should view this as ordinary-course compensation that modestly reinforces director-shareholder alignment but carries no material strategic or financial signal.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Hay Laura J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	562	$77.85	$44K

Holdings After Transaction: Common Stock — 3,701 shares (Direct)

Footnotes (1)

1. [object Object]

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hay Laura J

(Last) (First) (Middle)

METLIFE, INC.

200 PARK AVE

(Street)

NEW YORK NY 10166

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/17/2025		A(1)		562	A	$77.85	3,701	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Remarks:

	/s/ Morgan Mayes, Authorized Signer	06/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many MetLife (MET) shares did director Laura J. Hay acquire?

562 shares of common stock were reported as acquired.

What was the reported transaction price for the MET shares?

The Form 4 lists a price of $77.85 per share.

What is Laura Hay’s total beneficial ownership after the transaction?

Her direct holdings increased to 3,701 shares of MetLife common stock.

Was the acquisition an open-market purchase?

No. The shares reflect a board retainer paid in stock and deferred under MetLife’s compensation plan.

Does the filing involve any derivative securities?

No derivative securities were reported in Table II of the Form 4.